Online Program Home
My Program

Abstract Details

Activity Number: 263
Type: Contributed
Date/Time: Monday, August 1, 2016 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract #320946
Title: Robust Rules for Imputation of Binary Toxicity or Efficacy Indicators for Use in BCRM
Author(s): Tao Feng* and Aaron Camp and Joseph Adair and Kevin Lawson
Companies: and PPD and PPD and PPD
Keywords: Robust Rules ; Imputation ; Toxicity ; Efficacy ; bCRM
Abstract:

In many phase I clinical trials, it is desirable to use a dose-selection algorithm capable of incorporating toxicity and efficacy data. For example, in the trials for rare disease such as hemophilia B where identifying and recruiting patients is a challenge, patient response data should be utilized whenever possible. A bivariate continual reassessment method (bCRM) was proposed by Braun in 2002. Bearing the characteristics of adaptive design, bCRM not only addresses limitations in the historically simplistic phase I maximum tolerated dose (3+3) design, it also incorporates efficacy information when identifying dose escalation. The original bCRM algorithm did not consider the case when there are missing data. In practice, it is very likely that either toxicity or efficacy outcome is not collected and therefore missing. For example, some trial might have a big window between collection of toxicity data and efficacy data. In this scenario, the likelihood of missing either the efficacy or toxicity data at a specific visit is very high. We plan to investigate several imputation rules for different scenarios and propose the most robust imputation rule and most conservative imputation rul


Authors who are presenting talks have a * after their name.

Back to the full JSM 2016 program

 
 
Copyright © American Statistical Association